Inhibiting angiogenesis can disrupt the blood supply to the tumor, leading to a lack of nutrients and oxygen. This can result in tumor necrosis and potentially reduce tumor growth and metastasis. Moreover, anti-angiogenic therapy can normalize abnormal tumor vasculature, improving the delivery of chemotherapeutic agents to the tumor site.
